TAXS, the IRS tax relief company, is the first publicly traded tax representation firm in the United States.
Started by Patrick R. Cox in 2001, TAXS offers services and counsel to taxpayers across the country facing seemingly insurmountable tax problems, and relief from substantial federal tax debt.
Employing over 300 people, TAXS leverages the expertise of ex-IRS agents, enrolled agents, attorneys, CPAs, and seasoned tax consultants ready to counsel and assist every day people with their specific tax issues.
The Internal Revenue Service (IRS) hangs like a threatening cloud over the heads of tens of thousands of taxpayers every year who find themselves swimming against the overpowering current of the IRS collections process.
Federal tax debt is serious and the IRS is a terrifying opponent for anyone with tax problems. The IRS is known to use questionable audit tactics, garnish your wages, put liens on your property, and levy the money in your bank accounts to satisfy your tax debt. And if they think you are intentionally withholding information or revenue, they can drown you with charges of evasion and even fraud.
You don’t have to live with the weight of unfair or substantial IRS debt if you don’t want to. The peace that accompanies tax resolution is within your reach today. All you have to do is stretch out and grab the lifeline TAXS offers.
You should consider that after each fiscal year during the five years that Mr. Cox’s shares are being held in escrow, Mr. Cox may claw back a portion of the escrowed shares based on a formula linked to the financial performance of TAXS. Any shares Mr. Cox does not claw back prior to June 30, 2015 will be turned over to the Company for cancellation.
As a result of the Financial Reorganization Agreement, shareholders will have an increased voting power in their stock. For example, a shareholder owning 1,000,000 shares of TAXS common stock will have an increase of the voting power of such stock from 0.3% of the voting power to 0.7% of the voting power.
More about TAXS at www.txmstr.com
Keep TAXS on your watch list, and be ready for possible pop!
******************************
Caleco Pharma Corp. (OTC.BB:CAEH)(Frankfurt:T3R)(WKN: A0N9Y0)(the “Company” or “Caleco”), a diversified healthcare company with biopharmaceutical and consumer health product development programs focused on the development of breakthrough products derived from natural sources including plant extracts, functional oils and probiotics, today reports that Caleco Pharma Europe, S.L. (”CPE”), an independent healthcare products company with operations in Barcelona, Spain, has informed Caleco that it will begin distribution of its lead product, LamiriDOSIN in September 2010. CPE obtained a European license to distribute and market LamiriDOSIN and other products Caleco has developed or is in the process of developing under the terms of a license agreement entered into by the parties in November, 2009.
Previously, CAEH reported that the company provide an update on the development of its products that target the global Hepatitis “C” prescription market - an estimated $4 Billion market - and the liver health maintenance market via a nutritional supplement formulation. Over 200 million persons are infected with chronic hepatitis C and less than 5% are treated with prescription medications today.
More about CAEH at www.calecopharmacorp.com
Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup
******************************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.read more Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement for services for Tax Masters Inc.(TAXS.OB) which has expired. Crown Equity Holdings, Inc. has received an additional four thousand dollars from the same third party (Marshall Curtis) for an additional 30 days of advertisement.
